404
Views
12
CrossRef citations to date
0
Altmetric
Reviews

Nano-lipidic formulation and therapeutic strategies for Alzheimer’s disease via intranasal route

, , &
Pages 572-593 | Received 01 May 2021, Accepted 24 Sep 2021, Published online: 09 Nov 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Carine Zuglianello & Elenara Lemos-Senna. (2022) The nanotechnological approach for nasal delivery of peptide drugs: a comprehensive review. Journal of Microencapsulation 39:2, pages 156-175.
Read now

Articles from other publishers (11)

Zahra Jafarisavari, Jafar Ai, Seyed Abbas Mirzaei, Mostafa Soleimannejad & Shiva Asadpour. (2024) Development of new nanofibrous nerve conduits by PCL-Chitosan-Hyaluronic acid containing Piracetam-Vitamin B12 for sciatic nerve: A rat model. International Journal of Pharmaceutics 655, pages 123978.
Crossref
Edoardo Agosti, Marco Zeppieri, Sara Antonietti, Luigi Battaglia, Tamara Ius, Caterina Gagliano, Marco Maria Fontanella & Pier Paolo Panciani. (2024) Navigating the Nose-to-Brain Route: A Systematic Review on Lipid-Based Nanocarriers for Central Nervous System Disorders. Pharmaceutics 16:3, pages 329.
Crossref
Rahul Nair, Priti Paul, Indrani Maji, Ujala Gupta, Srushti Mahajan, Mayur Aalhate, Santosh Kumar Guru & Pankaj Kumar Singh. (2024) Exploring the current landscape of chitosan-based hybrid nanoplatforms as cancer theragnostic. Carbohydrate Polymers 326, pages 121644.
Crossref
Ami Patel, Himanshu Paliwal, Krutika Sawant & Bhupendra Gopalbhai Prajapati. 2024. Alzheimer's Disease and Advanced Drug Delivery Strategies. Alzheimer's Disease and Advanced Drug Delivery Strategies 319 345 .
Bindiya Chauhan, Shivani Patel, Bhupendra Gopalbhai Prajapati & Sudarshan Singh. 2024. Alzheimer's Disease and Advanced Drug Delivery Strategies. Alzheimer's Disease and Advanced Drug Delivery Strategies 361 371 .
Arti Shettiwar, Ujala Gupta, Priti Paul, Rahul Nair, Mayur Aalhate, Srushti Mahajan, Indrani Maji, Santosh Kumar Guru, Neelesh Kumar Mehra & Pankaj Kumar Singh. (2023) A comprehensive review of the biomaterial-based multifunctional nanocarriers for therapeutic applications in breast cancer. Journal of Drug Delivery Science and Technology 89, pages 104990.
Crossref
Stuart Madden, Enrique Carrazana & Adrian L. Rabinowicz. (2023) Optimizing Absorption for Intranasal Delivery of Drugs Targeting the Central Nervous System Using Alkylsaccharide Permeation Enhancers. Pharmaceutics 15:8, pages 2119.
Crossref
Sankha Bhattacharya. (2023) Extravaganza of Nanobiotechnology in the Diagnosis and Treatment of Dementia Patients. Current Pharmaceutical Biotechnology 24:9, pages 1108-1121.
Crossref
Shehla Nasar Mir Najib Ullah, Obaid Afzal, Abdulmalik Saleh Alfawaz Altamimi, Hissana Ather, Shaheen Sultana, Waleed H. Almalki, Pragya Bharti, Ankit Sahoo, Khusbu Dwivedi, Gyas Khan, Shahnaz Sultana, Abdulaziz Alzahrani & Mahfoozur Rahman. (2023) Nanomedicine in the Management of Alzheimer’s Disease: State-of-the-Art. Biomedicines 11:6, pages 1752.
Crossref
Raquel Taléns-Visconti, Jesus Vicente de Julián-Ortiz, Ofelia Vila-Busó, Octavio Diez-Sales & Amparo Nácher. (2023) Intranasal Drug Administration in Alzheimer-Type Dementia: Towards Clinical Applications. Pharmaceutics 15:5, pages 1399.
Crossref
Esra Küpeli Akkol, Hilal Bardakcı, Çiğdem Yücel, Gökçe Şeker Karatoprak, Büşra Karpuz & Haroon Khan. (2022) A New Perspective on the Treatment of Alzheimer’s Disease and Sleep Deprivation-Related Consequences: Can Curcumin Help?. Oxidative Medicine and Cellular Longevity 2022, pages 1-23.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.